Indirect comparisons in the comparative efficacy and non-inferiority settings

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

(2011) David C. Hoaglin et al.   VALUE IN HEALTH

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

(2011) Jeroen P. Jansen et al.   VALUE IN HEALTH

The potential for bias in reporting of industry-sponsored clinical trials

(2010) Stephen Pyke et al.   PHARMACEUTICAL STATISTICS

Making available information from studies sponsored by the pharmaceutical industry: some current practices

(2010) Michael O'Kelly et al.   PHARMACEUTICAL STATISTICS

Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials

(2010) James Matcham et al.   PHARMACEUTICAL STATISTICS

PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial

(2010) Patrick Peterson et al.   Statistics in Biopharmaceutical Research

Use of Indirect and Mixed Treatment Comparisons for Technology Assessment

(2008) Alex Sutton et al.   PHARMACOECONOMICS

Preservation of effect and the regulatory approval of new treatments on the basis of non-inferiority trials

(2007) Steven Snapinn et al.   STATISTICS IN MEDICINE